🇺🇸 FDA
Patent

US 9044482

Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

granted A61KA61K31/015A61K31/167

Quick answer

US patent 9044482 (Use of aminoindane compounds in treating overactive bladder and interstitial cystitis) held by Asana BioSciences, LLC expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/015, A61K31/167, A61K31/40, A61K31/435